1887

Abstract

A monoclonal antibody (C3) produced against foot-and-mouth disease virus type OCaseros was found to neutralize quadrivalent monoclonal antibody escape mutant (G67) of foot-and-mouth disease virus type OKaufbeuren. This mutant had been characterized at the sequence level as having distinct changes affecting four non-overlapping neutralizable sites. The C3 monoclonal antibody was used to prepare a quintuple escape mutant from the G67 and a single escape mutant from the parental OKaufbeuren viruses. Polyclonal postvaccinated and infected cattle sera as well as polyclonal mouse and guinea-pig sera, which neutralized the quadrivalent mutant, no longer neutralized the quintuple mutant, indicating that a fifth site had been identified and that changing the fifth site eliminated all neutralization. The site was characterized using serological techniques and found to be conformationally dependent, trypsin-sensitive and independent of sites previously characterized by monoclonal antibodies. Amino acid sequencing comparing parental, single C3 and quintuple mutants showed that a single change from a glutamine to a histidine, at amino acid 149 in the structural protein VP1, (1D) characterized the C3 mutation. The fifth site probably represents a conformational epitope which is formed due to the interaction of the VP1 loop region with other surface amino acids.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-8-1547
1993-08-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/8/JV0740081547.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-8-1547&mimeType=html&fmt=ahah

References

  1. Haresnape JM, McCahon D. 1983; Four independent antigenic determinants on the capsid polypeptides of aphthovirus.. Journal of General Virology 64:2345–2355
    [Google Scholar]
  2. Kärber G. 1931; Beitrag zur kollektiven behandlung pharmakologischer Reihenversuche.. Archiv für experimentelle Pathologie und Pharmakologie 162:480–483
    [Google Scholar]
  3. Kitson JDA, McCahon D, Belsham GJ. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.. Virology 179:26–34
    [Google Scholar]
  4. Knowles NJ. 1990; A method for direct nucleotide sequencing of foot-and-mouth disease virus RNA for epidemiological studies.. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Lindholm, Denmark25–29June 1990 appendix 06–112 Rome: FAO;
    [Google Scholar]
  5. McCahon D, Crowther JR, Belsham GJ, Kitson JDA, Duchesne M, Have P, Meloen RH, Morgan DO, De Simone F. 1989; Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.. Journal of General Virology 70:639–645
    [Google Scholar]
  6. McCullough KC, Crowther JR, Butcher RN. 1985; Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody.. Journal of Immunological Methods 82:91–100
    [Google Scholar]
  7. McCullough KC, Crowther JR, Carpenter WC, Brocchi E, Capucci L, De Simone F, Xie Q, McCahon D. 1987; Epitopes on foot-and-mouth disease virus particles. I. Topology.. Virology 157:516–525
    [Google Scholar]
  8. Ouldridge EJ, Barnett PV, Parry NR, Syred A, Head M, Rweyamamu MM. 1984; Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.. Journal of General Virology 65:2033–2040
    [Google Scholar]
  9. Parry N, Fox G, Rowlands D, Fry S, Acharya R, Logan D, Stuart D. 1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.. Nature, London 347:569–572
    [Google Scholar]
  10. Pfaff E, Theil HJ, Beck E, Strohmaier K. 1988; Analysis of neutralizing epitopes on foot-and-mouth disease virus.. Journal of Virology 62:2033–2040
    [Google Scholar]
  11. Samuel AR, Knowles NJ, Samuel GD, Crowther JR. 1991; Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus using monoclonal antibodies.. Biologicals 19:299–310
    [Google Scholar]
  12. Sanger F, Nicklen S, Coulson AR. 1977; DNA sequencing with chain-terminating inhibitors.. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
  13. Thomas AAM, Woortmeder RJ, Puijk W, Barteling SJ. 1988; Antigenic sites on foot-and-mouth disease virus type A10.. Journal of Virology 62:2782–2789
    [Google Scholar]
  14. Xie QC, McCahon D, Crowther JR, Belsham GJ, McCullough KC. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.. Journal of Virology 68:1637–1647
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-8-1547
Loading
/content/journal/jgv/10.1099/0022-1317-74-8-1547
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error